4 March 2024 - The manufacturers of 10 high cost drugs selected for the US Medicare program's first-ever pricing negotiations have submitted counter offers to the US Government's initial proposal, US President Joe Biden said on Monday.
The negotiation program, passed as part of 2022's Inflation Reduction Act, allows Medicare to negotiate prices for the high cost drugs. Medicare covers Americans aged 65 and above.